These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32310830)

  • 21. Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.
    Li H; Mittal A; Makonchuk DY; Bhatnagar S; Kumar A
    Hum Mol Genet; 2009 Jul; 18(14):2584-98. PubMed ID: 19401296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PITX2 Enhances the Regenerative Potential of Dystrophic Skeletal Muscle Stem Cells.
    Vallejo D; Hernández-Torres F; Lozano-Velasco E; Rodriguez-Outeiriño L; Carvajal A; Creus C; Franco D; Aránega AE
    Stem Cell Reports; 2018 Apr; 10(4):1398-1411. PubMed ID: 29641992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clock regulator Bmal1 protects against muscular dystrophy.
    Gao H; Xiong X; Lin Y; Chatterjee S; Ma K
    Exp Cell Res; 2020 Dec; 397(1):112348. PubMed ID: 33130178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
    Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of muscle formation by the fusogenic micropeptide myomixer.
    Bi P; Ramirez-Martinez A; Li H; Cannavino J; McAnally JR; Shelton JM; Sánchez-Ortiz E; Bassel-Duby R; Olson EN
    Science; 2017 Apr; 356(6335):323-327. PubMed ID: 28386024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with rGDF11 does not improve the dystrophic muscle pathology of mdx mice.
    Rinaldi F; Zhang Y; Mondragon-Gonzalez R; Harvey J; Perlingeiro RCR
    Skelet Muscle; 2016; 6():21. PubMed ID: 27303621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myomaker is a membrane activator of myoblast fusion and muscle formation.
    Millay DP; O'Rourke JR; Sutherland LB; Bezprozvannaya S; Shelton JM; Bassel-Duby R; Olson EN
    Nature; 2013 Jul; 499(7458):301-5. PubMed ID: 23868259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low Six4 and Six5 gene dosage improves dystrophic phenotype and prolongs life span of mdx mice.
    Yajima H; Kawakami K
    Dev Growth Differ; 2016 Aug; 58(6):546-61. PubMed ID: 27224259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo myomaker-mediated heterologous fusion and nuclear reprogramming.
    Mitani Y; Vagnozzi RJ; Millay DP
    FASEB J; 2017 Jan; 31(1):400-411. PubMed ID: 27825107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regenerative capacity of the dystrophic (mdx) diaphragm after induced injury.
    Matecki S; Guibinga GH; Petrof BJ
    Am J Physiol Regul Integr Comp Physiol; 2004 Oct; 287(4):R961-8. PubMed ID: 15191902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-function analysis of myomaker domains required for myoblast fusion.
    Millay DP; Gamage DG; Quinn ME; Min YL; Mitani Y; Bassel-Duby R; Olson EN
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2116-21. PubMed ID: 26858401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors.
    Matre PR; Mu X; Wu J; Danila D; Hall MA; Kolonin MG; Darabi R; Huard J
    Stem Cells; 2019 Dec; 37(12):1615-1628. PubMed ID: 31574188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Satellite Cells in Muscular Dystrophy - Lost in Polarity.
    Chang NC; Chevalier FP; Rudnicki MA
    Trends Mol Med; 2016 Jun; 22(6):479-496. PubMed ID: 27161598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COUP-TFII regulates satellite cell function and muscular dystrophy.
    Xie X; Tsai SY; Tsai MJ
    J Clin Invest; 2016 Oct; 126(10):3929-3941. PubMed ID: 27617862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice.
    Hindi SM; Shin J; Ogura Y; Li H; Kumar A
    PLoS One; 2013; 8(8):e72121. PubMed ID: 23977226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle-specific deletion of SLK/Stk2 enhances p38 activity and myogenesis in mdx mice.
    Pryce BR; Labrèche C; Hamoudi D; Abou-Hamad J; Al-Zahrani KN; Hodgins JJ; Boulanger-Piette A; Bossé S; Balog-Alvarez C; Frénette J; Ardolino M; Kornegay JN; Sabourin LA
    Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118917. PubMed ID: 33259860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
    He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
    Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myomaker and Myomerger Work Independently to Control Distinct Steps of Membrane Remodeling during Myoblast Fusion.
    Leikina E; Gamage DG; Prasad V; Goykhberg J; Crowe M; Diao J; Kozlov MM; Chernomordik LV; Millay DP
    Dev Cell; 2018 Sep; 46(6):767-780.e7. PubMed ID: 30197239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Satellite cells from dystrophic (mdx) mice display accelerated differentiation in primary cultures and in isolated myofibers.
    Yablonka-Reuveni Z; Anderson JE
    Dev Dyn; 2006 Jan; 235(1):203-12. PubMed ID: 16258933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle.
    Chakkalakal JV; Michel SA; Chin ER; Michel RN; Jasmin BJ
    Hum Mol Genet; 2006 May; 15(9):1423-35. PubMed ID: 16551657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.